| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |